Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

NVO 44.08 -0.07 (-0.16%)
price chart
Notable Drug Stocks: Novo Nordisk A/S (NYSE:NVO), Pharmacyclics (NASDAQ ...
Novo Nordisk A/S (ADR) (NYSE:NVO) recently released its own EP&L. Novo Nordisk A/S (ADR) (NYSE:NVO) shares after opening at $45.32 moved to $45.50 on last trade day and at the end of the day closed at $45.20.
Drug Manufacturers: Teva Pharmaceutical Industries (NYSE:TEVA), Dynavax ...
Novo Nordisk A/S (ADR) (NYSE:NVO) (Analyst Report) has a strong presence in the diabetes care market with one of the broadest diabetes portfolios in the industry.
MannKind, Top Gainer In The Biopharmaceutical Industry Yesterday
MannKind has spent more than $2 billion over seven years developing the drug. The insulin analogs market has been dominated for years by two drugs, produced by Eli Lilly and Company (LLY) and Novo Nordisk A/S (ADR) (NVO). Novo Nordisk's drug ...
Related articles »  
Zosano Pharma and Novo Nordisk start cooperation